Suscribirse

Endoscopic papillary balloon dilation for the management of bile duct stones in patients 85 years of age and older - 23/08/11

Doi : 10.1016/j.gie.2007.10.066 
Yukiko Ito, MD, Takeshi Tsujino, MD , Osamu Togawa, MD, Natsuyo Yamamoto, MD, Hiroyuki Isayama, MD, Ryo Nakata, MD, Takao Kawabe, MD, Masao Omata, MD
Current affiliations: Department of Gastroenterology, Japanese Red Cross Medical Center (Y.I., T.T., R.N.), Department of Gastroenterology, Faculty of Medicine, University of Tokyo (T.T., O.T., H.I., M.O.), Department of Gastroenterology, International University of Health and Welfare, Mita Hospital (N.Y.), Department of Endoscopy and Endoscopic Surgery, Faculty of Medicine, University of Tokyo (T.K.), Tokyo, Japan 

Reprint requests: Takeshi Tsujino, MD, Department of Gastroenterology, Faculty of Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, 113-8655, Tokyo, Japan.

Tokyo, Japan

Abstract

Background

Endoscopic papillary balloon dilation (EPBD) is a possible alternative to endoscopic sphincterotomy for the treatment of bile duct stones. However, little information is available in the elderly.

Objective

Our purpose was to evaluate the safety and efficacy of EPBD for bile duct stones in patients of 85 years of age and older.

Design

Retrospective study from a single center.

Setting

Tertiary care facility with experience in bile duct stone removal with EPBD.

Patients

A total of 406 patients (74 patients ≥85 years old, group A; 332 patients <85 years old, group B) with bile duct stones underwent EPBD.

Main Outcome Measurements

Efficacy and safety of EPBD between the 2 groups. Baseline patient characteristics were also evaluated.

Results

The mean American Society of Anesthesiologists score in group A was significantly higher compared with that in group B (2.4 [0.5] vs 1.9 [0.7], P < .0001). Patients received anticoagulants more frequently and had larger and more numerous stones in group A than in group B with significant differences. Overall, bile duct clearance rates were similar in the 2 groups (91% vs 95%), but the mean number of sessions required for complete stone removal was significantly higher in group A (1.6 vs 1.4, P = .0081). The incidence of overall early complications after EPBD was lower in group A than in group B (2.7% vs 8.4%) but was not statistically different. None of the patients in group A had post-EPBD pancreatitis, whereas pancreatitis occurred in 5.7% in group B (P = .036). Bleeding was not observed after EPBD in 406 patients, including 7 patients in group A who received anticoagulation therapy at the time of EPBD. There was no significant difference in the cumulative stone nonrecurrence rate between group A and group B (log-rank test, P = .6225).

Conclusions

EPBD is a safe and effective technique for the treatment of bile duct stones even in high-risk elderly patients without an increased risk of pancreatitis and bleeding. Because the evaluation of outcomes might be biased by our study design (an open study), further studies are needed.

El texto completo de este artículo está disponible en PDF.

Abbreviations : ASA, EML, EPBD, EST


Esquema


© 2008  American Society for Gastrointestinal Endoscopy. Publicado por Elsevier Masson SAS. Todos los derechos reservados.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 68 - N° 3

P. 477-482 - septembre 2008 Regresar al número
Artículo precedente Artículo precedente
  • EUS accurately predicts the need for therapeutic ERCP in patients with a low probability of biliary obstruction
  • Jan Janssen, Ali Halboos, Lucas Greiner
| Artículo siguiente Artículo siguiente
  • Endoscopic balloon dilation of the sphincter of Oddi for stone extraction in the elderly: is the juice worth the squeeze?
  • James A. DiSario

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

@@150455@@ Voir plus

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2026 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.